0.0001
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
21,123.0000
45,139.0000
26,477.0000
Total Liabilities Net Minority Interest
31,783.0000
22,755.0000
16,247.0000
Total Equity Gross Minority Interest
-10,660.0000
22,384.0000
10,230.0000
Total Capitalization
-2,103.0000
34,380.0000
16,606.0000
Common Stock Equity
-10,660.0000
22,384.0000
10,230.0000
Capital Lease Obligations
847.0000
1,461.0000
422.0000
Net Tangible Assets
-10,660.0000
22,384.0000
10,230.0000
Working Capital
-2,962.0000
33,525.0000
16,055.0000
Invested Capital
1,877.0000
34,380.0000
21,845.0000
Tangible Book Value
-10,660.0000
22,384.0000
10,230.0000
Total Debt
13,384.0000
13,457.0000
12,037.0000
Share Issued
2,166.3560
2,176.7820
1,008.7720
Ordinary Shares Number
2,166.3560
2,166.2480
1,003.9290
Treasury Shares Number
--
10.5340
4.8430
12/31/2020 - 12/11/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
CMRA Comera Life Sciences Holdings, Inc.
0.0002
0.00%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
KRBP Kiromic BioPharma, Inc.
0.8200
0.00%
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
AVTE Aerovate Therapeutics, Inc.
2.6200
0.00%
TRVN Trevena, Inc.
1.6700
+5.70%
IMRN Immuron Limited
2.0420
-4.58%
GDTC CytoMed Therapeutics Limited
2.6400
+5.18%
RGBP Regen BioPharma, Inc.
0.0621
0.00%